SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Ironwood Pharmaceuticals and Forest Laboratories, Inc. to Host Conference Call to Discuss FDA Approval of LINZESSTM (Linaclotide) for the Treatment of Irritable Bowel Syndrome With Constipation and Chronic Idiopathic Constipation